Search Results - "Sils, Brian"

Cost-sharing and adherence, clinical outcomes, health care utilization, and costs: A systematic literature review by Fusco, Nicole, Sils, Brian, Graff, Jennifer S, Kistler, Kristin, Ruiz, Kimberly

“…US health plans are adopting benefit designs that shift greater financial burden to patients through higher deductibles, additional copay tiers, and…”
Get full text

Medicaid best price reforms to enable innovative payment models for cell and gene therapies by Quinn, Casey, Ciarametaro, Michael, Sils, Brian, Phares, Sharon, Trusheim, Mark

“…Cell and gene therapies promise durable benefits but face financial challenges from the uncertainty in their performance. Value-based purchasing arrangements…”
Get more information

Specialty drug and health care utilization vary by wage level in employer-sponsored health plans by Sherman, Bruce W, Sils, Brian, Kamin, Leah, Westrich, Kimberly

Get full text

What might have happened: the impact of interrupting entry of innovative drugs on disease outcomes in the United States by Herring, William, Ciarametaro, Michael, Mauskopf, Josephine, Wamble, David, Sils, Brian, Dubois, Robert

“…The study estimated the extent to which drug innovations over the past 30 years may have improved outcomes for six diseases. We analyzed six diseases (ischemic…”
Get more information

Value-based performance arrangements for chronic conditions: an economic simulation of Medicaid Drug Rebate Program reforms by Quinn, Casey, Ciarametaro, Michael, Sils, Brian, Phares, Sharon, Trusheim, Mark R

“…Changes to the Medicaid Drug Rebate Program (MDRP) determination of Medicaid Best Price (MBP) enables Value-based purchasing arrangements (VBPAs) to address…”
Get more information

The RASSF1A Tumor Suppressor Regulates XPA-Mediated DNA Repair by Donninger, Howard, Clark, Jennifer, Rinaldo, Francesca, Nelson, Nicholas, Barnoud, Thibaut, Schmidt, M. Lee, Hobbing, Katharine R., Vos, Michele D., Sils, Brian, Clark, Geoffrey J.

“…RASSF1A may be the most frequently inactivated tumor suppressor identified in human cancer so far. It is a proapoptotic Ras effector and plays an important…”
Get full text